Fulminant Type 1 Diabetes Mellitus Accompanied by Positive Conversion of Anti-insulin Antibody after the Administration of Anti-CTLA-4 Antibody Following the Discontinuation of Anti-PD-1 Antibody

An 80-year-old woman with malignant melanoma received 20 cycles of anti-programmed death 1 (PD-1) antibody (nivolumab) treatment and showed normal glucose tolerance. Three weeks after switching to anti-cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) antibody (ipilimumab), her plasma glucose lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiba, Michiru, Inaba, Hidefumi, Ariyasu, Hiroyuki, Kawai, Shintaro, Inagaki, Yuko, Matsuno, Shohei, Iwakura, Hiroshi, Yamamoto, Yuki, Nishi, Masahiro, Akamizu, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096029/
https://www.ncbi.nlm.nih.gov/pubmed/29491310
http://dx.doi.org/10.2169/internalmedicine.9518-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096029/
https://www.ncbi.nlm.nih.gov/pubmed/29491310
http://dx.doi.org/10.2169/internalmedicine.9518-17

Ejemplares similares